This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, routine vaccination would unlikely be cost-savings but may still be cost-effective.

Author(s): Widdowson MA, Meltzer MI, Zhang X, et al.

Published: 2007

Resource types: Peer-reviewed journal

Diseases: Rotavirus

Topics: Immunization financing; Disease/vaccine specific information

Regions: North America and Europe